|Late breaker submission closed 25 November. Latebreaker decisions was communicated to authors in December 2018.
Abstract submission closed 15 October. Abstract decisions was communicated to authors in November 2018.
Aims and eligibility
HepHIV abstracts should contain original material from recent work that is not yet in publication. The HepHIV conference encourages research on testing and linkage to care as well as best practice examples and lessons learned. Also abstracts on integrated testing and linkage to care of key populations within the fields of viral hepatitis, HIV, STIs and TB are encouraged.
Please see below list of topics/ tracks available for submitted abstracts for HepHIV 2019:
1. Integrated testing hepatitis/HIV/TB/STI
2. New testing technologies to increase testing coverage, e.g. home-based HIV testing/sampling (HIV, hepatitis)
3. Capacity building in HIV and/or viral hepatitis testing
4. Monitoring and evaluation of HIV and/or viral hepatitis testing
5. Cost-effectiveness of HIV and/or viral hepatitis testing strategies
6. Linkage to care for HIV and/or viral hepatitis
7. Stigma and legal and regulatory barriers for HIV and hepatitis testing
8. Combination prevention
If your abstract is accepted, the registration for the conference will be waived, but all costs related to the conference participation should be covered by you, including flight and accommodation. A special rate for accommodation at the venue is available please use this link to book before December 15, 2018.
Depending on available funding the conference will offer a small number of scholarship covering accommodation and/or flight for authors with accepted abstracts/latebreakers. Deadline for submitting a scholarship application was 1 December, 2018.
Priority will be given to:
- Applicants with accepted abstracts;
- Applicants from Central and Eastern European and Central Asian countries as well as members of community organisations;
- Investigators under 35 years